+Search query
-Structure paper
Title | Homotypic fibrillization of TMEM106B across diverse neurodegenerative diseases. |
---|---|
Journal, issue, pages | Cell, Vol. 185, Issue 8, Page 1346-1355.e15, Year 2022 |
Publish date | Apr 14, 2022 |
Authors | Andrew Chang / Xinyu Xiang / Jing Wang / Carolyn Lee / Tamta Arakhamia / Marija Simjanoska / Chi Wang / Yari Carlomagno / Guoan Zhang / Shikhar Dhingra / Manon Thierry / Jolien Perneel / Bavo Heeman / Lauren M Forgrave / Michael DeTure / Mari L DeMarco / Casey N Cook / Rosa Rademakers / Dennis W Dickson / Leonard Petrucelli / Michael H B Stowell / Ian R A Mackenzie / Anthony W P Fitzpatrick / |
PubMed Abstract | Misfolding and aggregation of disease-specific proteins, resulting in the formation of filamentous cellular inclusions, is a hallmark of neurodegenerative disease with characteristic filament ...Misfolding and aggregation of disease-specific proteins, resulting in the formation of filamentous cellular inclusions, is a hallmark of neurodegenerative disease with characteristic filament structures, or conformers, defining each proteinopathy. Here we show that a previously unsolved amyloid fibril composed of a 135 amino acid C-terminal fragment of TMEM106B is a common finding in distinct human neurodegenerative diseases, including cases characterized by abnormal aggregation of TDP-43, tau, or α-synuclein protein. A combination of cryoelectron microscopy and mass spectrometry was used to solve the structures of TMEM106B fibrils at a resolution of 2.7 Å from postmortem human brain tissue afflicted with frontotemporal lobar degeneration with TDP-43 pathology (FTLD-TDP, n = 8), progressive supranuclear palsy (PSP, n = 2), or dementia with Lewy bodies (DLB, n = 1). The commonality of abundant amyloid fibrils composed of TMEM106B, a lysosomal/endosomal protein, to a broad range of debilitating human disorders indicates a shared fibrillization pathway that may initiate or accelerate neurodegeneration. |
External links | Cell / PubMed:35247328 / PubMed Central |
Methods | EM (helical sym.) |
Resolution | 2.7 - 23.0 Å |
Structure data | EMDB-26268, PDB-7u0z: EMDB-26273, PDB-7u10: EMDB-26274, PDB-7u11: EMDB-26275, PDB-7u12: EMDB-26276: TMEM106B(120-254) singlet amyloid fibril from frontotemporal lobar degeneration with TDP-43 pathology (FTLD-TDP) type A (case 4). EMDB-26277, PDB-7u14: EMDB-26278, PDB-7u15: EMDB-26279, PDB-7u16: EMDB-26281: TMEM106B(120-254) singlet amyloid fibril from dementia with Lewy bodies (DLB). EMDB-26282: TMEM106B(120-254) doublet amyloid fibril from dementia with Lewy bodies (DLB). EMDB-26283: Low-resolution map of tau filament from progressive supranuclear palsy (PSP) case 3. EMDB-26284: TMEM106B(120-254) singlet amyloid fibril from progressive supranuclear palsy (PSP) case 1. EMDB-26285: TMEM106B(120-254) singlet amyloid fibril from progressive supranuclear palsy (PSP) case 2. EMDB-26286: TMEM106B(120-254) doublet amyloid fibril from progressive supranuclear palsy (PSP) case 2. EMDB-26287: EMDB-26288: EMDB-26289: EMDB-26290: EMDB-26291: EMDB-26292: EMDB-26293: EMDB-26294: EMDB-26295: EMDB-26296: |
Chemicals | ChemComp-NAG: |
Source |
|
Keywords | PROTEIN FIBRIL / Tau protein / Amyloid fibril / TMEM106B / TRANSPORT PROTEIN / UNKNOWN FUNCTION |